Demand for weight-loss medications, including popular brands like Ozempic and Wegovy, continues to rise. A recent study revealed that one in eight Americans has used or is currently using these drugs ...

She ended up taking a second job to afford it. When Rice reached her goal weight, she tried phasing out semaglutide (marketed as Wegovy for weight loss and Ozempic for diabetes), using smaller and ...

In the obesity space, Novo Nordisk reported data from a Phase III trial showing that a high dose of Wegovy elicited more weight loss than the approved regimen—but still fell short of results posted by ...

Ozempic and Wegovy have been added to Medicare's list of drugs whose prices will be negotiated between drug makers and the government. There's a lot of uncertainty on which direction the Trump ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...

Results from the STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight loss effects the drug is known for. Novo Nordisk has announced topline results from the ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

About 140,400 obese patients in Massachusetts were prescribed medications such as Wegovy and Zepbound in 2024, a 255 percent increase from 2023, according to a Globe analysis of insurance claims ...

The study published in Nature Medicine is unique in its scope, marking a milestone in the study of new-generation weight-loss drugs such as Ozempic, Wegovy and Mounjaro, which have already somewhat ...

Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable. In the Phase IIIb STEP UP trial, 7.2mg Wegovy demonstrated statistically ...